References and Notes
1
Wall ME.
Wani MC.
Cook CE.
Palmer KH.
MacPhail AT.
Sim GA.
J.
Am. Chem. Soc.
1966,
88:
3888
2a
Hecht SM.
Newman DJ.
Kingston DGI.
J.
Nat. Prod.
2000,
63:
1273
2b
Das B.
Madhusudan P.
Reddy PV.
Anita Y.
Indian J. Chem., Sect. B
2001,
40:
453
2c
Kitajima M.
Yoshida S.
Yamagata K.
Nakamura M.
Takayama H.
Saito K.
Seki H.
Aimi N.
Tetrahedron
2002,
58:
9169
2d
Puri SC.
Verma V.
Amna T.
Quzi GN.
Spiteller M.
J.
Nat. Prod.
2005,
68:
1717
3a
Hsiang YH.
Hertzberg R.
Hecht SM.
Liu LF.
J.
Biol. Chem.
1985,
260:
14873
3b
Khon KW.
Pommier Y.
Ann. N.
Y. Acad. Sci.
2000,
922:
11
3c
Staker BL.
Hjerrild K.
Feese MD.
Behnke CA.
Burgin AB.
Stewart L.
Proc. Natl. Acad. Sci. U. S. A.
2002,
99:
15387
4
Kingsbury WD.
Boehm JC.
Jakas DR.
Holden KG.
Hecht SM.
Gallagher G.
Caranfa MJ.
McCabe FL.
Faucette LF.
Johnson RK.
Hertzberg RP.
J.
Med. Chem.
1991,
34:
98
5a
Negoro S.
Fukuoka M.
Masuda N.
Takada M.
Kusunoki Y.
Matsui K.
Takifuji N.
Kudoh S.
Niitani H.
Taguchi T.
J.
Natl. Cancer Inst.
1991,
83:
1164
5b
Kawato Y.
Aonuma M.
Hirata Y.
Kuga H.
Sato K.
Cancer
Res.
1991,
51:
4187
6
Priel E.
Showalter SD.
Blair DG.
AIDS Res. Hum. Retroviruses
1991,
7:
65
7a
Cragg GM.
Newman DJ.
J. Nat. Prod.
2004,
67:
232
7b
Butler MS.
J. Nat. Prod.
2005,
22:
162
For reviews on camptothecin and
its derivatives, see:
8a
Hutchison CR.
Tetrahedron
1981,
37:
1047
8b
Wall ME.
Wani MC. In The Alkaloids
Vol. 50:
Cordell
GA.
Academic
Press;
San Diego CA:
1998.
Chap.
13.
p.509
8c
Du W.
Tetrahedron
2003,
59:
8649 ; and references cited therein
8d
Twin H.
Batey RA.
Org. Lett.
2004,
6:
4913
8e
Yu J.
Depne J.
Kronenthal D.
Tetrahedron
Lett.
2004,
45:
7247
8f
Thomas OP.
Dumas C.
Zaparucha A.
Husson HP.
Eur.
J. Org. Chem.
2004,
5:
1128
8g
Rahier NJ.
Cheng K.
Gao R.
Eisenhauser BM.
Hecht SM.
Org. Lett.
2005,
7:
835
8h
Anderson RJ.
Raolji GB.
Kanazawa A.
Greene AE.
Org.
Lett.
2005,
7:
2989
8i
Brunin T.
Hénichart J.-P.
Rigo B.
Tetrahedron
2005,
61:
7916
8j
Tangirala RS.
Dixon R.
Yang D.
Ambrus A.
Antony S.
Agama K.
Pommier Y.
Curran DP.
Bioorg. Med. Chem.
Lett.
2005,
15:
4736
8k
Li Q.-Y.
Zu Y.-G.
Shi R.-Z.
Yao L.-P.
Curr. Med. Chem.
2006,
13:
2021
8l
Tang C.-J.
Babijak M.
Anderson RJ.
Greene AE.
Kanazawa A.
Org.
Biomol. Chem.
2006,
4:
3757
8m
Tangirala RS.
Antony S.
Agama S.
Pommier Y.
Anderson BD.
Bevins R.
Curran DP.
Bioorg.
Med. Chem.
2006,
14:
6202
8n
Elban MA.
Sun W.
Eisenhauer BM.
Gao R.
Hecht SM.
Org. Lett.
2006,
16:
3513
8o
Brumin T.
Legentil L.
Henichart J.-P.
Rigo B.
Tetrahedron
2006,
62:
3959
8p
Dai W.
Petersen JL.
Wang KK.
Org. Lett.
2006,
8:
4665
8q
Xiao X.
Antony S.
Pommier Y.
Cushman M.
J. Med. Chem.
2006,
49:
1408
8r
Peters R.
Althaus M.
Nagy A.-L.
Org.
Biomol. Chem.
2006,
4:
498
8s
Hiroya K.
Kawamoto K.
Sakamoto T.
Synlett
2006,
2636
8t
Peters R.
Althaus M.
Nagy AL.
Org.
Biomol. Chem.
2006,
4:
498
8u
Zhou HB.
Liu GS.
Yao ZJ.
Org. Lett.
2007,
9:
2003
9a
Chavan SP.
Venkatraman MS.
Tetrahedron Lett.
1998,
39:
6745
9b
Chavan SP.
Sivappa R.
Tetrahedron Lett.
2004,
45:
3113
9c
Chavan SP.
Pasupathy K.
Venkatraman MS.
Kale RR.
Tetrahedron
Lett.
2004,
45:
6879
9d
Chavan SP.
Sivappa R.
Tetrahedron
Lett.
2004,
45:
3941
9e
Chavan SP.
Venkatraman MS.
Arkivoc
2005,
165
9f
Chavan SP.
Pathak AB.
Kalkote UR.
Tetrahedron Lett.
2007,
48:
6561
9g
Chavan SP.
Pathak AB.
Kalkote UR.
Synlett
2007,
2635
10
Ram RN.
Charles I.
Tetrahedron
1997,
53:
7335
11
Su J.
Qiu G.
Liang S.
Hu X.
Synth.
Commun.
2005,
35:
1427
12
Rapoport H.
Tang CSF.
Morrow CJ.
J. Am. Chem. Soc.
1975,
97:
159
13
Comins DL.
Hao H.
Saha JK.
Gao J.
J. Org. Chem.
1994,
59:
5120
14 All compounds were characterized by
IR, ¹H NMR,
¹³C
NMR, and MS analysis.
Spectral Data
Compound 8: ¹H NMR (200 MHz,
CDCl3): δ = 0.90 (t, J = 7.4
Hz, 3 H), 1.24 (t, J = 7.1
Hz, 3 H), 1.40 (t, J = 7.3
Hz, 3 H), 1.70-1.81 (m, 1 H), 1.92-2.04 (m, 1
H), 3.5 (t, J = 7.4 Hz,
1 H), 4.13 (q, J = 7.1,
2 H), 4.45 (q, J = 7.3
Hz, 2 H), 5.09 (d, J = 14.4
Hz, 1 H), 5.17 (d, J = 14.4
Hz, 1 H), 6.28 (d, J = 7.2
Hz, 1 H), 7.24 (d, J = 7.2
Hz, 1 H), 7.29-7.35 (s, 5 H).
Compound 9: ¹H NMR (200 MHz,
CDCl3): δ = 0.92 (t, J = 7.4
Hz, 3 H), 1.26 (t, J = 7.2
Hz, 3 H), 1.35 (t, J = 7.3
Hz, 3 H), 1.51-1.71 (m, 2 H), 1.82-1.96 (m, 1
H), 2.21-2.50 (m, 1 H), 3.22-3.42 (m, 2 H), 3.60-3.73
(m, 1 H), 4.15 (q, J = 7.2
Hz, 2 H), 4.36 (q, J = 7.3
Hz, 2 H), 4.49 (d, J = 14.7 Hz,
1 H), 4.66 (d, J = 14.7
Hz, 1 H), 7.24-7.30 (m, 5 H).
Compound 14: ¹H NMR (200 MHz,
CDCl3): δ = 0.96 (t, J = 7.4
Hz, 3 H), 1.24 (t, J = 7.1
Hz, 3 H), 1.60-1.77 (m,
1 H), 1.92-2.10
(m, 1 H), 4.13 (q, J = 7.1
Hz, 2 H), 4.96 (t, J = 7.3
Hz, 1 H), 5.13 (s, 2 H), 6.30 (d, J = 7.2
Hz, 1 H), 7.42 (d, J = 7.2
Hz, 1 H), 7.31-7.38 (m, 5 H), 10.52 (s, 1 H).
Compound 6: ¹H NMR (400 MHz;
CD3OD): δ = 0.93 (t, J = 7.3
Hz, 3 H), 1.86 (q, J = 7.2
Hz, 2 H), 5.22 (d, J = 16.2 Hz,
1 H), 5.41 (d, J = 16.2
Hz, 1 H), 6.63 (d, J = 6.8
Hz,
1 H), 7.46 (d, J = 6.8
Hz, 1 H).
15
Typical Procedure
for Compound 9
To a stirred solution of keto compound 10 (5 g, 29.4 mmol) in dry CH2Cl2 benzyl
amine (3.21 mL, 29.4 mmol) was added dropwise at r.t. and allowed
to stir for 20 min. After the completion of the reaction (TLC),
K2CO3 (14.2 g, 102.9 mmol) was added followed
by dropwise addition of ethyl malonyl chloride (4.89 mL, 38.22 mmol)
at 0 ˚C. The mixture was stirred at r.t. until
completion (1 h, TLC), and then was filtered, and the residue was
washed with CH2Cl2 (3 × 30
mL). The organic layer was washed with H2O, brine, dried
over anhyd Na2SO4, filtered, and concentrated
on a rotary evaporator under diminished pressure. The resulting residue
was purified by flash column chromatography (silica gel) using EtOAc-PE
(3:7) as an eluent, affording the dihydropyridone 9 as
a colorless liquid (7.6 g, 70% yield).